Clinical trial
An Open-Label Study to Assess the Hemodynamic Effect and the Safety of TX000045 After 16 Weeks of Treatment in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
NCT07473700 is registered in ClinicalTrials.gov with Tectonic Operating Company, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study to Assess the Hemodynamic Effect and the Safety of TX000045 After 16 Weeks of Treatment in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Lead sponsor
- Tectonic Operating Company, Inc.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 31, 2026
- Completion date
- December 11, 2027
- Enrollment
- 25 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.